Page last updated: 2024-12-07

4-acryloylmorpholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-acryloylmorpholine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID98723
CHEMBL ID3187188
SCHEMBL ID36422
SCHEMBL ID9914378
MeSH IDM0519389

Synonyms (47)

Synonym
n-acryloylmorpholine
n-acrylylmorpholine
4-acryloylmorpholine
inchi=1/c7h11no2/c1-2-7(9)8-3-5-10-6-4-8/h2h,1,3-6h
morpholine, 4-(1-oxo-2-propenyl)-
5117-12-4
nsc-162221
nsc162221
4-acryloylmorpholine, 97%, contains 1,000 ppm monomethyl ether hydroquinone as inhibitor
A0841
1-morpholin-4-ylprop-2-en-1-one
NCGC00256280-01
dtxsid0044947 ,
tox21_301658
cas-5117-12-4
dtxcid8024947
AKOS005207052
2-propen-1-one, 1-(4-morpholinyl)-
ec 418-140-1
k0y58p61ja ,
nsc 162221
4-(1-oxo-2-propenyl)-morpholine
4-(1-oxo-2-propenyl)morpholine
unii-k0y58p61ja
FT-0629859
1-morpholinoprop-2-en-1-one
(1-oxo-2-propenyl)morpholine
acryloyl morpholine
acryloylmorpholine
SCHEMBL36422
1-(morpholin-4-yl)prop-2-en-1-one
SCHEMBL9914378
4-acryloylmorpholine #
n-acrolylmorpholine
CHEMBL3187188
mfcd00047413
4-acryloylmorpholine (stabilized with mehq)
4-acryloylmorpholine, stabilized with 1000 ppm mehq
4-acryloylmorpholine, (stabilized with mehq)
E77211
Q27281799
1-(4-morpholinyl)-2-propen-1-one
3-(difluoromethylene)-1,1,2,2-tetrafluorocyclopropane
A934924
1-(morpholin-4-yl)propenone, 4-(1-oxo-2-propenyl)morpholine, acryloylmorpholine, 4-acryloylmorpholine, 1-morpholinoprop-2-en-1-one
BS-23203
CS-0158052
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency41.77500.006038.004119,952.5996AID1159521; AID1159523
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency61.64480.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency76.95880.003041.611522,387.1992AID1159553
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency34.66540.023723.228263.5986AID743223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's6 (60.00)24.3611
2020's2 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.69 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index59.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]